Latest

Latest antibody News | Page 2

  • Latest antibody news stories and updates. What is happening today? All recent antibody news and developments. Live coverage and timeline of antibody. All you need to know about antibody.
Dr Michelle Boyle named 2023 CSL Centenary Fellow
NATURE publishes data on DUNP19 receptors role in cancer growth
Live Intracellular Imaging with New, Conditionally Active Immunofluorescence Probe
Enhertu continues to demonstrate clinically meaningful tumour response
TGA provisionally approves Moderna bivalent Covid vaccine for use as booster dose in adults
CSL starts planning to submit new antibody treatment
CSL Announces Positive Results for Garadacimab
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Enhertu approved in US as first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell
Starpharma announces new research agreement for DEP drug delivery platform
Datopotamab deruxtecan-based combinations show promising clinical activity
Enhertu approved in EU for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based
Interim statement on composition of current Covid vaccines
Enhertu reduced risk of disease progression or death by 50% vs. chemotherapy
Secrets of thymus formation revealed
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
TGA receives application for an increased dose of GlaxoSmithKline’s Covid treatment sotrovimab for BA.2 Omicron sublineage
QuickStart to treatment for hepatitis C
More COVID medicines for most at-risk New Zealanders
Fewer antibody diversity as we age
There is more to Sars-CoV-2 than meets eye
New mathematical model predicts effectiveness of Covid vaccines
WHO updates its treatment guidelines to include molnupiravir
Patrys selects stable cell line for production of PAT-DX3
Enhertu significantly improved both progression-free and overall survival in DESTINY-Breast04 trial
WHO prequalifies first monoclonal antibody – tocilizumab – to treat Covid
Exercise post-vaccine bumps up antibodies
Covid community surveillance project launches
First patient dosed in Telix ‘ProstACT’ therapeutic program
Enhertu granted Priority Review in US for patients with HER2-positive metastatic breast cancer treated with prior anti-HER2-based
WHO recommends two new drugs to treat Covid
Early data for multivariant Covid vaccine booster shows promise
New Covid drug approved that can treat and prevent Covid
ATAGI statement on Omicron variant
ATAGI statement on Omicron variant and timing of Covid booster vaccination
Enhertu additional analyses further reinforce ground-breaking efficacy
TGA Provisional Approval of Celltrion Healthcare Australia Pty Ltd Covid treatment, regdanvimab
TGA Provisional Approval of Roche Products Pty Ltd Covid treatment, tocilizumab
Antibodies help keep harmful forms of gut fungi in check
Classification of Omicron: SARS-CoV-2 Variant of Concern
Year-to-date and Q3 2021 results
New Covid drug saves lives and cuts time in hospital
Two vaccine doses boost antibody levels in airways after Covid
Pictor and SCIENION partner to commercialise high-throughput SARS-CoV-2 antibody testing system to support ongoing fight against
TGA grants provisional determination to Roche Products Pty Ltd Covid treatment tocilizumab
EnGeneIC launches trial of nano cellular Covid vaccine
AstraZeneca Covid and RSV presentations at IDWeek 2021 will showcase scientific progress in infectious diseases

© 2024 - The National Tribune Australia